CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Allopurinaldrug
Likely dose
Allopurinal 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00823199
NCT00823199N/ACompleted
CompareCT.gov

An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia

Bronx Psychiatric Center·interventional·Posted Jan 15, 2009·Updated Aug 21, 2018

In Brief

A clinical study evaluating Allopurinal for Schizophrenia. Completed, enrolled 10 participants.

Detailed Summary

This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10) poorly responsive patients with schizophrenia, monitoring their response and side-effects. No change in medication is required.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 15, 2009
Enrollment StartNov 1, 2005
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.5 years ago

Interventions

Allopurinaldrug

300mg once daily by mouth for four weeks